Literature DB >> 9101910

[Surgical therapy of pancreatic carcinoma in elderly patients over 70].

A Richter1, M Schwab, D Lorenz, B Rumstadt, M Trede.   

Abstract

Between October 1972 and December 1994, 519 pancreatic resections were performed at the Chirurgische Universitätsklinik Mannheim, 372 for pancreatic carcinoma. Of 328 patients who underwent a partial duodenopancreatectomy for cancer, 45 patients were older than 70 years: only in one case a partial duodenopancreatectomy was performed for chronic pancreatitis. In comparison to all patients the perioperative morbidity increased to 39.1% (21.5% vs. 39.1%). The perioperative mortality of all patients was 1.9%, the mortality of patients older than 70 years was 4.3%. The mean survival time of 28 patients who died subsequently was 30.6 (5-96) months. Despite increased perioperative morbidity and mortality, the patient's age is not considered to be a limiting factor to an attempt at curative resection of pancreatic or periampullary cancer.

Entities:  

Mesh:

Year:  1996        PMID: 9101910

Source DB:  PubMed          Journal:  Langenbecks Arch Chir Suppl Kongressbd        ISSN: 0942-2854


  4 in total

1.  Pancreatic resection in elderly patients: should it be denied?

Authors:  M Adham; L C Bredt; M Robert; J Perinel; C Lombard-Bohas; T Ponchon; P J Valette
Journal:  Langenbecks Arch Surg       Date:  2014-03-27       Impact factor: 3.445

2.  Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy.

Authors:  Ioannis Hatzaras; Carl Schmidt; Dori Klemanski; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  J Am Coll Surg       Date:  2011-01-12       Impact factor: 6.113

Review 3.  What is the effect of age on pancreatic resection?

Authors:  Taylor S Riall
Journal:  Adv Surg       Date:  2009

4.  The effect of age on short-term outcomes after pancreatic resection: a population-based study.

Authors:  Taylor S Riall; Deepthi M Reddy; William H Nealon; James S Goodwin
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.